High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma

PURPOSE: Many patients with asthma still have insufficient disease control, despite the availability of effective treatment options. A substantial proportion of patients appear to rely more on short-acting beta(2)-agonist (SABA) rather than on anti-inflammatory maintenance treatment. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Baron, Anna Jetske, Flokstra-de Blok, Bertine M J, Kerstjens, Huib A M, Koopmans-Klein, Gineke, Price, David B, Sellink, Andrea A, Tsiligianni, Ioanna, Kocks, Janwillem W H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285233/
https://www.ncbi.nlm.nih.gov/pubmed/34285512
http://dx.doi.org/10.2147/JAA.S292943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285233/
https://www.ncbi.nlm.nih.gov/pubmed/34285512
http://dx.doi.org/10.2147/JAA.S292943

Ejemplares similares